Journal of Mammary Gland Biology and Neoplasia

, Volume 14, Issue 1, pp 11–17

Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework

Article

DOI: 10.1007/s10911-009-9114-z

Cite this article as:
Debeb, B.G., Xu, W. & Woodward, W.A. J Mammary Gland Biol Neoplasia (2009) 14: 11. doi:10.1007/s10911-009-9114-z

Abstract

Meta-analyses of tens of thousands of women treated with radiation as a component of their breast cancer treatment have shown that radiation improves overall survival from breast cancer in women with early stage and advanced disease. However, data suggest that breast cancer stem/progenitor cells can be enriched after radiation and that breast cancer stem/progenitor clonogens are particularly resistant to radiation. Potentially resistant breast cancer stem/progenitor populations appear to be over-represented in estrogen receptor negative breast cancer and indeed, clinically these cancers are more resistant to radiation than estrogen receptor positive breast cancers. Emerging pre-clinical data suggest that targeting cancer stem/progenitor survival pathways may lead to effective radiosensitization in subgroups of patients with resistant disease. Herein, preclinical studies are reviewed in the context of the clinical framework.

Keywords

Cancer initiating cellsStem cellsRadiobiologyDNA repairRadiocurabilityRadiation toxicityClonogens

Abbreviations

IR

Ionizing radiation

Sca1

stem cell antigen 1

ATM

ataxiatelangiectasia-mutated

EGF

epidermal growth factor

bFGF

basic fibroblast growth factor

DNA

deoxyribonucleic acid

ROS

reactive oxygen species

MECs

mammary epithelial cells

ER

estrogen receptor

HSCs

hematopoetic stem cells

TICs

tumor-initiating cells

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Radiation OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Division of Radiation OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA